Revolutionizing Healthcare with Early Disease Detection
Quanterix, a company developing technology designed to enable earlier disease detection, made its market debut on Thursday. Shares of the company surged after pricing at $15 a share, and opening at $16.25 a share. Kevin Hrusovsky, CEO of Quanterix, was with us to discuss how the company plans to revolutionize healthcare.
The fourth-leading cause of death is drug side effects, and drugs only work half the time, says Hrusovsky. He believes that if you can personalize the drugs, you have an opportunity to improve the whole pharmaceutical industry.
Quanterix is developing technology that will digitize how they see into blood, and help to see disease long before there are symptoms. Rocket science is being deployed into the blood, says Hrusovsky. He says that if you can see biomarkers and incorporate into fitbits, it can really help improve health.
From breakthrough vodka to sustainable jet fuel, Air Company's CEO takes us inside their Brooklyn research lab and talks the future of carbon technology
Celebrity dentist Dr. Michael Apa explains the rising demand in cosmetic veneers and building the perfect smile for clients like Jennifer Lopez and Kylie Jenner
Wooly Mammoths, Dodo Birds, and Thylacines - Oh my! Ben Lamm, CEO and Co-Founder of Colossal, talks De-extinction and his company's plan to "Re-wild" the world.
